Malignant Intestinal Neoplasm — Trials

Malignant Intestinal Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

7,773 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,666
Recruiting: 939
Ph III recruiting: 109
Growth YoY: +12.2%
Industry share: 21%
Top sponsor: Fudan University
Termination share: 25.7%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (772)

clinicaltrialsPublishedShowing 201–250 of 711 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06364384	Radical Concurrent Chemoradiotherapy With DDP/5-FU and PD-1 Antibody for Non-metastatic Rectal Squamous Cell Carcinoma	recruiting	Phase 2	20	Sixth Affiliated Hospital, Sun Yat-sen UniversityOTHER	1	Jul 1, 2026	clinicaltrials
NCT07079631	A Clinical Study to Test if an Investigational Treatment Called BNT314 When Used in Combination With Another Investigational Treatment Pumitamig (BNT327) and Chemotherapy, is Beneficial and Safe for Patients With Advanced Colorectal Cancer	recruiting	Phase 1 / Phase 2	482	BioNTech SEINDUSTRY